Acyclovir Therapy

Acyclovir Therapy is a pharmacotherapeutic intervention that belongs to the class of antiviral treatments and is specifically distinguished by its use of the nucleoside analogue acyclovir to selectively inhibit herpes simplex virus (HSV) DNA replication in the management of sexually transmitted infections caused by HSV types 1 and 2.

2.5K

Publications

129.4K

Citations

9.5K

Authors

2.2K

Institutions

Publications per year

2017–2026

247

Authors

9.5K

  1. LC
    Lawrence Corey

    University of Washington, United States

    60 publications · 7K citations

    36

    h-index

  2. ED
    Erik De Clercq

    Rega Institute for Medical Research, Belgium

    53 publications · 2.7K citations

    32

    h-index

  3. AW
    Anna Wald

    University of Washington, United States

    38 publications · 3.6K citations

    26

    h-index

  4. HH
    Henry H. Balfour

    University of Minnesota, United States

    29 publications · 3.7K citations

    23

    h-index

  5. RJ
    Richard J. Whitley

    University of Alabama at Birmingham, United States

    23 publications · 4.8K citations

    22

    h-index

1–5 of 9.5K

Venues

  1. The Journal of Infectious Diseases

    JID · 110 publications · 8.3K citations

    58

    h-index

  2. Antimicrobial Agents and Chemotherapy

    AAC · 179 publications · 11.1K citations

    57

    h-index

  3. PubMed

    Repository · 212 publications · 7.6K citations

    46

    h-index

  4. Clinical Infectious Diseases

    CID · 53 publications · 4.4K citations

    35

    h-index

  5. The American Journal of Medicine

    53 publications · 2.4K citations

    30

    h-index

1–5